Apparent Radiological Improvement in an Infant With Labrune Syndrome Treated With Bevacizumab

Pediatr Neurol. 2020 Nov:112:53-55. doi: 10.1016/j.pediatrneurol.2020.07.011. Epub 2020 Jul 25.

Authors

Marina Martínez-Matilla¹, Jesús José Ferre-Fernández², María José Aparisi², Ana Victoria Marco-Hernández³, Juan Antonio Cerón⁴, Yanick J Crow⁵, Francisco Martínez-Castellano⁴, Miguel Tomás-Vila³, Laia Pedrola²

Affiliations

¹ Genomic Unit, Health Research Institute La Fe (IIS La Fe), Valencia, Spain. Electronic address: marinamtnez@hotmail.com.
² Genomic Unit, Health Research Institute La Fe (IIS La Fe), Valencia, Spain.
³ Pediatric Neurology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁴ Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁵ MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

PMID: 32911264
DOI: 10.1016/j.pediatrneurol.2020.07.011

No abstract available

Keywords: Bevacizumab; Infant; Leukoencephalopathy with intracranial calcification and cysts; SNORD118.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bevacizumab / administration & dosage
Bevacizumab / pharmacology*
Calcinosis / diagnostic imaging*
Calcinosis / drug therapy*
Central Nervous System Cysts / diagnostic imaging*
Central Nervous System Cysts / drug therapy*
Humans
Immunologic Factors / administration & dosage
Immunologic Factors / pharmacology*
Infant
Leukoencephalopathies / diagnostic imaging*
Leukoencephalopathies / drug therapy*
Magnetic Resonance Imaging
Male
RNA, Small Nucleolar

Substances

Immunologic Factors
Leukoencephalopathy Brain Calcifications and Cysts
RNA, Small Nucleolar
SNORD118 RNA, human
Bevacizumab